Heidi Henson

Heidi Henson has over 25 years of solid financial operations experience with both public and private companies. Prior to Pardes, she was Chief Financial Officer of Imbria Pharmaceuticals. She served as Chief Financial Officer and Secretary of Kura Oncology (NASDAQ:KURA) and Chief Financial Officer of Wellspring Biosciences and its parent company Araxes Pharma. Heidi also served as Vice President, Finance at Intellikine until its acquisition by Takeda.

Before joining Intellikine, Heidi served as an independent financial consultant assisting with various start-up activities for early stage companies, SEC reporting and Sarbanes-Oxley implementation and compliance. She began her career in auditing at PricewaterhouseCoopers. She received a Bachelor of Accountancy from the University of San Diego and is a certified public accountant (inactive) in the state of California.